Genevieve Moyer, MD

Provider's Specialties

Hematology/Oncology
Internal Medicine
Oncology

Provider's location(s)

Location information is not available.

Patient ratings

Read reviews

CU AMC - Hemophilia & Thrombosis Center

(303)724-0724

Insurance plans accepted

We participate with most major health insurance plans and national transplant networks.

View the full list

Prepare for your visit

We want to make sure you know what to expect before you arrive.

See the checklist

My care philosophy

I believe strongly in the importance of getting to know each patient as an individual and engaging them in shared decision making. To accomplish this, I strive to ensure that all my patients understand their diagnosis so that they feel empowered in the pursuit of their own health and wellness.

Get to know Genevieve Moyer, MD

Conditions Treated

Clotting Disorders
Bleeding Disorders
Blood Disorders

Languages spoken

English

Experience and background

At the time I entered my hematology/oncology fellowship, I was eager to pursue clinical research in the area of cancer-associated thrombosis. I chose to study the venous thromboembolism characteristics of individuals from our institution who received stem cell transplantation, focusing on differences between cord blood and non-cord blood recipients. I discovered that not only was post-transplant thrombosis a serious problem, but that these patients were also at an extremely high risk of bleeding with anticoagulation. As a result of this endeavor, I have developed a career interest aimed at developing tools to risk stratify complex patients regarding their risk for bleeding and clotting simultaneously. As my career has progressed, I have also discovered a passion for the treatment of women with bleeding disorders which has led to a goal of balancing our knowledge and understanding of bleeding disorders across genders. I continue to pursue the development of novel tools to aid in bleeding and clotting risk stratification while also spending time investigating these knowledge gaps regarding how to best care for women, transgender, and gender non-binary individuals with disorders of hemostasis.

Undergraduate 2007

Arizona State University (AZ)

Medical Education 2011

Saint Louis University School of Medicine

Residency 2015

Saint Louis University School of Medicine Program

Graduate 2018

University of Colorado Denver

Fellowship 2018

Saint Louis University School of Medicine Program

For Patients:
At the time I entered my hematology/oncology fellowship, I was eager to pursue clinical research in the area of cancer-associated thrombosis. I chose to study the venous thromboembolism characteristics of individuals from our institution who received stem cell transplantation, focusing on differences between cord blood and non-cord blood recipients. I discovered that not only was post-transplant thrombosis a serious problem, but that these patients were also at an extremely high risk of bleeding with anticoagulation. As a result of this endeavor, I have developed a career interest aimed at developing tools to risk stratify complex patients regarding their risk for bleeding and clotting simultaneously. As my career has progressed, I have also discovered a passion for the treatment of women with bleeding disorders which has led to a goal of balancing our knowledge and understanding of bleeding disorders across genders. I continue to pursue the development of novel tools to aid in bleeding and clotting risk stratification while also spending time investigating these knowledge gaps regarding how to best care for women, transgender, and gender non-binary individuals with disorders of hemostasis.

For Referring Providers: